Pharmacogenomics Validation for Imatinib in Chronic Myeloid Leukemia

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

October 31, 2012

Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Trial Locations (3)

Unknown

Princess Margaret Hospital, University of Toronto, Toronto

Asan Medical Center, University of Ulsan College of Medicine, Seoul

Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER